Hribernik, N. et al. 2025. Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy. Radiology and Oncology. 59, 1 (Feb. 2025), 43–53.